Skip to content

A cohort study of combined Chinese and Western medicine in the treatment of chronic kidney disease

A cohort study of combined Chinese and Western medicine in the treatment of chronic kidney disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2024000108
Enrollment
Unknown
Registered
2024-06-23
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney disease

Interventions

Grouping based on whether patients voluntarily accept oral Chinese herbal decoctions :None

Sponsors

Affiliated Hospital of Changchun University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for CKD in the Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guidelines (2012) of the International Kidney Disease Organization. 2. = 10 years. 3. Be able to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Diagnosis of one of the following diseases: polycystic kidney, human immunodeficiency virus infection, cirrhosis of the liver, multiple myeloma. 2. Conditions deemed severe or unsuitable for participation in the study by the attending physician. 3. Concurrently participate in other interventional clinical trials. 4. Unable to cooperate in completing the assessment of cognitive function or have comorbidities that interfere with the assessment of cognitive function such as intracranial tumors, traumatic brain injuries, visualization, and hearing pathology. 5. CKD caused by systemic inflammatory diseases or autoimmune diseases such as lupus erythematosus. 6. Pregnant or breastfeeding women. 7. Patients with hereditary renal disease.

Design outcomes

Primary

MeasureTime frame
Cardiovascular event;All-cause mortality;Kidney disease event;

Secondary

MeasureTime frame
Hypersensitive C-reactive protein;Heart rate;Renal function;Blood pressure;Glycated hemoglobin;Food frequency questionnaire;Funduscopy examination;N-terminal pro-brain natriuretic peptide;Blood routine test;Electrolyte;Blood lipid test;Liver function;Anemia test; Urine routine test;Grip power;Urinary tract ultrasound examination;Urine albumin/urine creatinine ratio;Parathyroid hormone determination;Ultrasonic cardiogram;Life quality assessment;Fasting blood glucose;

Countries

China

Contacts

Public ContactShoulin Zhang

Affiliated Hospital of Changchun University of Chinese Medicine

shoulin-z@163.com+86 15948000552

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026